Diagnostic Evaluations of Autism Spectrum Disorder during the COVID-19 Pandemic.
Document Type
Article
Publication Date
2-2022
Identifier
DOI: 10.1007/s10803-021-04960-7; PMCID: PMC7970766
Abstract
A global pandemic has significantly impacted the ability to conduct diagnostic evaluations for autism spectrum disorder (ASD). In the wake of the coronavirus, autism centers and providers quickly needed to implement innovative diagnostic processes to adapt in order to continue serve patient needs while minimizing the spread of the virus. The International Collaborative for Diagnostic Evaluation of Autism (IDEA) is a grassroots organization that came together to discuss standards of care during the pandemic and to provide a forum wherein providers communicated decisions. This white paper is intended to provide examples of how different centers adjusted their standard approaches to conduct diagnostic evaluations for ASD during the pandemic and to provide insight to other centers as they go through similar challenges.
Journal Title
Journal of autism and developmental disorders
Volume
52
Issue
2
First Page
962
Last Page
973
MeSH Keywords
Autism Spectrum Disorder; Autistic Disorder; COVID-19; Humans; Pandemics; SARS-CoV-2
Keywords
Autism; COVID-19; Diagnostic evaluations
Recommended Citation
Jang J, White SP, Esler AN, et al. Diagnostic Evaluations of Autism Spectrum Disorder during the COVID-19 Pandemic. J Autism Dev Disord. 2022;52(2):962-973. doi:10.1007/s10803-021-04960-7
Comments
Grant support